• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Adherium’s smart inhaler tech chosen for EU mobile health program

December 12, 2016 By Sarah Faulkner

Adherium's smart inhaler tech chosen for EU mobile health programAdherium Ltd. (ASK:ADR) said today that its Smartinhaler was chosen for the myAirCoach program as a part of the European Union’s Horizon 2020 Framework for Research and Innovation. The Horizon 2020 program is the largest EU research and innovation program ever established, with €80 billion (nearly $85 billion) of funding available from 2014 until 2020.

The myAirCoach program was developed to evaluate if home monitoring and mobile health technology can be predictive for patients who suffer from asthma. The program’s primary goals is to help asthma patients manage their symptoms and enhance the adherence and effectiveness of their prescribed regimens.

Melbourne, Australia-based Ahderium touted its respiratory disease management tool in a recently published study, which demonstrated a significant reduction in hospitalization over the course of a year for patients using Smartinhaler. The company will supply a range of products to the program, including devices for inhaled medications by AstraZeneca (NYSE:AZN) and GlaxoSmithKline (NYSE:GSK).

“Successful disease management and prevention is only truly achieved by understanding the real-world complexity of our lives. The best way to do that is through rich data collected in the real world. By providing our innovative solutions to people with asthma, we can help people take the right medicine, at the right dose, at the right time and in the right way,” founder & CEO Garth Sutherland said in prepared remarks. “The myAirCoach programme is a leading initiative assessing the impact that digital health solutions, such as Smartinhaler, can have on patients in a real-world setting. It is a major international project, funded by the prestigious European Union Horizon 2020 framework.”

Imperial College London, the University of Manchester and the Leiden University Medical Center are participating in the myAirCoach project, which is expected to run for the next year.

“The myAirCoach program will help asthma sufferers to manage their health through user-friendly tools that will increase awareness of their clinical state as well as their adherence and the effectiveness of medical treatment they follow,” Dr. Omar Usmani, from the Imperial College London, said.

“People with asthma are more likely to miss school or work and experience reduced quality of life,” Fan Chung, from the Imperial College London, added. “We are excited about the collaboration between Adherium and myAirCoach which is expected to set the basis for the widespread adoption of sensor-based self-management systems across the spectrum of respiratory diseases.”

Filed Under: Drug-Device Combinations, Featured, mHealth (Mobile Health), Pharmaceuticals, Respiratory, Wall Street Beat Tagged With: Adherium, AstraZeneca plc, GlaxoSmithKline plc

IN CASE YOU MISSED IT

  • Flat Medical partners with Mercury Medical on smart syringe distribution
  • Glucotrack to effect a reverse stock split
  • Medtronic unveils ‘MiniMed’ as name for soon-to-be separated Diabetes unit
  • Insulet, Marvel collab to unveil comic book hero with type 1 diabetes
  • Insulet rolls out new Omnipod 5 iPhone app for use with Dexcom G7

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS